Remove australia-news health
article thumbnail

Medicines for migraines, reflux and cancer to become cheaper in Australia

The Guardian - Pharmaceutical Industry

The health minister, Mark Butler, on Monday announced Australians will have expanded access to some medicines from 1 October, saving $130m a year in out-of-pocket costs.

66
article thumbnail

‘Looming global health crisis’: urgent action needed to prevent spread of drug-resistant superbugs, CSIRO says

The Guardian - Pharmaceutical Industry

Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup Continue reading.

66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cancer researchers unable to access clinical trial data for top-selling drugs, study finds

The Guardian - Pharmaceutical Industry

The authors of a study published in the journal JAMA Oncology on Friday said the lack of transparency should be concerning to Australia. Sign up to receive an email with the top stories from Guardian Australia every morning Continue reading.

article thumbnail

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

STAT

But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the drug will aggravate racial disparities in elder care , KFF Health News explains. Drugmakers are asking the U.S. nationals injured by acts of international terrorism.

article thumbnail

GSK Reports the US FDA Acceptance of sBLA for Jemperli (dostarlimab) to Treat dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

PharmaShots

The sBLA of dostarlimab will be reviewed by health authorities in the US, Australia, Canada, Switzerland, Singapore & the UK under the Project Orbis Ref: GSK | Image: GSK Related News:- GSK Reports EMA’s Validation of MAA for Jemperli (dostarlimab) to Treat dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer PharmaShots!

40
article thumbnail

Online Medical Resources

RX Note

IWK Compounding Formulas USP-NF WHO Pharmacopoeia Pregnancy Australia TGA Best Use of Medicines in Pregnancy Pregnancy and Breastfeeding Medicines Guide Introduction This post is soley created as a portal for online medical resources. Some of the resources require personal subscription to access.

article thumbnail

UK, Moderna formalise 10-year vaccines alliance

pharmaphorum

The first vaccines are due to be produced at the new facility in 2025. The biotech will also work with the UK Health Security Agency (UKHSA) to ensure early vaccine development against emerging threats, in a bid to get from “variant to vaccine” within 100 days.

Vaccines 122